Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Patient Advocacy

Shaping the Future of Patient Advocacy: Anticipating Key Trends and Developments by 2030

Patient advocacy stands at the forefront of patient-centered care, dedicated to enhancing treatment outcomes and...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical Affairs

This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...

A Guide to Creating a Robust Patient Engagement Strategy

Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Health Literacy

Health Literacy – Cactus Life Sciences Leads the Way

It’s our responsibility as an industry to emphasize the importance of health literacy and help...
Patient Inclusivity Survey - PM360 and Cactus Life Sciences

Patient Inclusivity Survey

How many life sciences companies are actually making an effort to include patients in things...

Learn more ABOUT our company.